Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;57(1):33-38.
doi: 10.3347/kjp.2019.57.1.33. Epub 2019 Feb 26.

Immune Response of BALB/c Mice toward Putative Calcium Transporter Recombinant Protein of Trichomonas vaginalis

Affiliations

Immune Response of BALB/c Mice toward Putative Calcium Transporter Recombinant Protein of Trichomonas vaginalis

Tahali Mendoza-Oliveros et al. Korean J Parasitol. 2019 Feb.

Abstract

Trichomoniasis is a common sexually transmitted infection caused by Trichomonas vaginalis, which actually does not exist a vaccine for control or prevention. Thus, the identification of new and potent immunogens in T. vaginalis, which can contribute to the development of a vaccine against this parasite, is necessary. Therefore, the aim of this work was to evaluate the potential of a recombinant Transient Receptor Potential-like channel of T. vaginalis (TvTRPV), as a promising immunogen in BALB/c mice. First, TvTRPV was cloned and expressed as a recombinant protein in Escherichia coli BL21 cells and purified by nickel affinity. Next, BALB/c mice were immunized and the antibody levels in mice serum and cytokines from the supernatant of macrophages and from co-culture systems were evaluated. Recombinant TvTRPV triggered high levels of specific total IgG in sera from the immunized mice. Also, a statistically significant increase of cytokines: IL-1β, IL-6, and TNF-α after stimulation with the corresponding antigens in vitro, was identified. Moreover, co-cultures using CD4+ T cells from immunized mice were able to identify higher levels of IL-10 and IFN-γ. These results were useful to validate the immunogenicity of TvTRPV in BALB/c mice, where IL-10-IFN-γ-secreting cells could play a role in infection control, supporting the potential of TvTRPV as a promising target for vaccine against T. vaginalis.

Keywords: BALB/c mouse; TRPV channel; Trichomonas vaginalis; immune response; recombinant protein.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Prokaryotic expression and purification of recombinant TvTRPV. 0 hr, E. coli BL21 not induced; 24 hr, induction time after adding 1 mM IPTG; IF, insoluble fraction of induced cells; SF, soluble fraction of induced cells; W1 and W2, washings E1 and E2, TvTRTPV protein obtained by elution; MW, molecular weight marker.
Fig. 2
Fig. 2
Effect of recombinant TvTRPV on the macrophages 1L-1β, IL-6 and TNF-α production. Each bar represents the mean value±standard deviation (SD). Significance was accepted by comparison with the unimmunized control: (C-), (Dunnett, *P <0.05). Macrophages stimulated with LPS (1 μg/ml) were used as positive controls for cytokine production.
Fig. 3
Fig. 3
IFN-γ and IL-10 levels detected in co-culture system. Purified CD4+ T cells from immunized mice with different doses of recombinant TvTRPV (TvTRPV50, TvTRPV100, and TvTRPV200) stimulated with macrophages treated with different doses of recombinant TvTRPV (1, 10, and 100 μg). Co-culture systems were set up with 1:2 CD4+ T-cell:MØ. Each bar represents the mean value±standard deviation (SD). Significance was accepted by comparison with CD4+ T cells stimulated with macrophages without treatment: C (-), (Dunnett, *P<0.05).

References

    1. Menezes CB, Frasson AP, Tasca T. Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell. 2016;3:404–419. - PMC - PubMed
    1. Kissinger P, Adamski A. Trichomoniasis and HIV interactions: a review. Sex Transm Infect. 2013;89:426–433. - PMC - PubMed
    1. Lazenby GB, Taylor PT, Badman BS, McHaki E, Korte JE, Soper DE, Young Pierce J. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther. 2014;36:38–45. - PubMed
    1. Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis . Clin Microbiol Rev. 2004;17:783–793. - PMC - PubMed
    1. Xie YT, Gao JM, Wu YP, Tang P, Hide G, Lai DH, Lun ZR. Recombinant α-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis. Parasit Vectors. 2017;10:83. - PMC - PubMed

MeSH terms